Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma

被引:7
作者
Zhou, Xueliang [1 ]
Dou, Mengmeng [2 ]
Liu, Zaoqu [1 ]
Jiao, Dechao [1 ]
Li, Zhaonan [1 ]
Chen, Jianjian [1 ]
Li, Jing [1 ]
Yao, Yuan [1 ]
Li, Lifeng [3 ]
Li, Yahua [1 ]
Han, Xinwei [1 ]
机构
[1] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China
关键词
LONG NONCODING RNA; CANCER; MICRORNAS; IDENTIFICATION; PROLIFERATION; METASTASIS; BIOMARKERS; APOPTOSIS; DIAGNOSIS; PATHWAYS;
D O I
10.1155/2021/5518908
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Hepatocellular carcinoma (HCC) remains an important cause of cancer death. The molecular mechanism of hepatocarcinogenesis and prognostic factors of HCC have not been completely uncovered. Methods. In this study, we screened out differentially expressed lncRNAs (DE lncRNAs), miRNAs (DE miRNAs), and mRNAs (DE mRNAs) by comparing the gene expression of HCC and normal tissue in The Cancer Genome Atlas (TCGA) database. DE mRNAs were used to perform Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Then, the miRNA and lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a competitive endogenous RNA (ceRNA) network by weighted gene coexpression network analysis (WGCNA). Moreover, univariable Cox regression and Kaplan-Meier curve analyses of DE lncRNAs and DE mRNAs were conducted. Finally, the lasso-penalized Cox regression analysis and nomogram model were used to establish a new risk scoring system and predict the prognosis of patients with liver cancer. The expression of survival-related DE lncRNAs was verified by qRT-PCR. Results. A total of 1896 DEmRNAs, 330 DElncRNAs, and 76 DEmiRNAs were identified in HCC and normal tissue samples. Then, the turquoise miRNA and turquoise lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a ceRNA network by WGCNA. In this ceRNA network, there were 566 lncRNA-miRNA-mRNA regulatory pairs, including 30 upregulated lncRNAs, 16 downregulated miRNAs, and 75 upregulated mRNAs. Moreover, we screened out 19 lncRNAs and 14 hub mRNAs related to prognosis from this ceRNA network by univariable Cox regression and Kaplan-Meier curve analyses. Finally, a new risk scoring system was established by selecting the optimal risk lncRNAs from the 19 prognosis-related lncRNAs through lasso-penalized Cox regression analysis. In addition, we established a nomogram model consisting of independent prognostic factors to predict the survival rate of HCC patients. Finally, the correlation between the risk score and immune cell infiltration and gene set enrichment analysis were determined. Conclusions. In conclusion, the results may provide potential biomarkers or therapeutic targets for HCC and the establishment of the new risk scoring system and nomogram model provides the new perspective for predicting the prognosis of HCC.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma
    Zhou, Jingmin
    Liu, Guanghua
    Wu, Xingcheng
    Zhou, Zhien
    Li, Jialin
    Ji, Zhigang
    DISEASE MARKERS, 2021, 2021
  • [42] A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses
    Cai, Guangzhen
    Zhu, Jinghan
    Ning, Deng
    Li, Ganxun
    Zhang, Yuxin
    Xiong, Yixiao
    Liang, Junnan
    Yu, Chengpeng
    Chen, Xiaoping
    Liang, Huifang
    Ding, Zeyang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Identification of cuproptosis-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma
    He, Ya
    Zhang, Hongxia
    Li, Jingang
    Zhou, Hui
    Wang, Fei
    Zhang, Guangliang
    Wen, Yuetao
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2024, 22 (01):
  • [44] A 9-lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus-positive hepatocellular carcinoma
    Liu, Honghong
    Zhao, Ping
    Jin, Xueyuan
    Zhao, Yanling
    Chen, Yongqian
    Yan, Tao
    Wang, Jianjun
    Wu, Liang
    Sun, Yongqiang
    MOLECULAR MEDICINE REPORTS, 2019, 20 (01) : 573 - 583
  • [45] Identification of a Potential PPAR-Related Multigene Signature Predicting Prognosis of Patients with Hepatocellular Carcinoma
    Xu, Wenfang
    Chen, Zhen
    Liu, Gang
    Dai, Yuping
    Xu, Xuanfu
    Ma, Duan
    Liu, Lei
    PPAR RESEARCH, 2021, 2021
  • [46] A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma
    Dai, Xiaoyan
    Jiang, Wei
    Ma, Liang
    Sun, Jie
    Yan, Xiaodi
    Qian, Jing
    Wang, Yan
    Shi, Yu
    Ni, Shujie
    Yao, Ninghua
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
  • [47] A pyroptosis-related gene signature provides an alternative for predicting the prognosis of patients with hepatocellular carcinoma
    Lin, Dezhao
    Chen, Zhuoyan
    Zeng, Yuan
    Ding, Yinrong
    Zhao, Luying
    Xu, Qian
    Yu, Fujun
    Song, Xian
    Zhu, Xiaohong
    BMC MEDICAL GENOMICS, 2023, 16 (01)
  • [48] To construct and validate a risk score model of angiogenesis-related genes to predict the prognosis of hepatocellular carcinoma
    Gao, Duangui
    Lu, Yuan
    Jiang, Tianpeng
    Duan, Qinghong
    Huang, Zhi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [49] A New Cuproptosis-Related lncRNAs Model for Predicting the Prognosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma and Validation of LINC01269
    Shi, Chuanbing
    Sun, Yintao
    Sha, Ling
    Gu, Xuefeng
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 6009 - 6027
  • [50] Development and Validation of a Carbohydrate Metabolism-Related Model for Predicting Prognosis and Immune Landscape in Hepatocellular Carcinoma Patients
    Huang, Hong-xiang
    Zhong, Pei-yuan
    Li, Ping
    Peng, Su-juan
    Ding, Xin-jing
    Cai, Xiang-lian
    Chen, Jin-hong
    Zhu, Xie
    Lu, Zhi-hui
    Tao, Xing-yu
    Liu, Yang-yang
    Chen, Li
    CURRENT MEDICAL SCIENCE, 2024, 44 (04) : 771 - 788